Featured
Last news
S. Korean president's lawyer says martial law bid sought to stop 'dictatorship'
Ousted South Korean leader Yoon Suk Yeol's lawyer on Thursday said his bid to impose martial law was aimed at thwarting a "legislative dictatorship" by the opposition-controlled parliament, as the president became the country's first sitting head of state to stand trial in a criminal case.
Delta offers $30,000 each to Toronto plane crash passengers
US airline Delta will offer $30,000 to each passenger on a plane that crashed as it landed at Toronto airport this week, the carrier told AFP on Wednesday.
Yoon becomes South Korea's first sitting president to go on criminal trial
Ousted South Korean leader Yoon Suk Yeol became the country's first sitting head of state to stand trial in a criminal case as hearings opened Thursday on his bid to impose martial law.
Aspire Biopharma Holdings, Inc. Announces the Execution of Securities Purchase Agreement
NEW YORK CITY, NY / ACCESS Newswire / February 20, 2025 / Aspire Biopharma, Inc. ("Aspire" or the "Company"), a developer of a multi-faceted patent-protected disruptive drug delivery mechanism technology (Nasdaq:ASBP)(Nasdaq:ASBPW), today announced that it entered into a definitive Securities Purchase Agreement (the "Agreement") on February 19, 2025, pursuant to which the Company issued to the Buyers a senior secured convertible debenture (the "Debenture"). The Debenture is only convertible in the event of a default or at the Company's discretion. The closing of the transaction is expected to occur on February 20, 2025 (the "Closing Date"). The transaction will result in gross proceeds to the Company of $3.0 million. Proceeds from the transaction will support the Company's general working capital and operating expenses.
Natural Products Expo West 2025 Agenda Ignites Innovation, Connection and Conscious Growth
ANAHEIM, CA / ACCESS Newswire / February 20, 2025 / The natural products industry is set to embark on an exhilarating journey of discovery and collaboration as Natural Products Expo West, the pinnacle event for natural, organic and conscious products, returns to the Anaheim Convention Center from March 4-7, 2025. This year's expo promises to be a transformative experience, uniting the CPG community in a vibrant showcase of innovation, education and inspiration.
Amphastar Pharmaceuticals to Release Fourth Quarter Earnings and Hold Conference Call on February 27, 2025
RANCHO CUCAMONGA, CA / ACCESS Newswire / February 20, 2025 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced that the Company will release results for its Fourth quarter of 2024 ended December 31, 2024, after the market closes on Thursday, February 27, 2025, and will hold a conference call to discuss its financial results at 2:00 p.m. Pacific Time.
NAB Show Partners With the Ankler to Launch Business of Entertainment Track
Hollywood's Game Changers Share Actionable Insights. Headliners Include WWE's Nick Khan and Paul "Triple H" Levesque.
CNS Pharmaceuticals to Present at the 18th Annual European Life Sciences CEO Forum
Webcast presentation Wednesday, February 26th at 3:20 PM CET
Dr. Amir Bajoghli and Skin & Laser Dermatology Center Introduce Ultherapy for Non-Invasive Skin Lifting and Tightening
MCLEAN, VIRGINIA / ACCESS Newswire / February 20, 2025 / Dr. Amir Bajoghli and the Skin & Laser Dermatology Center are proud to announce the introduction of Ultherapy, an FDA-cleared non-invasive procedure for lifting and tightening the skin on the face, neck, and chest. As the demand for non-surgical cosmetic treatments continues to grow, Dr. Bajoghli and his team remain committed to offering the most advanced and effective solutions for their patients' aesthetic needs.
Lexaria's Strategic Business Pursuit of DehydraTECH-Liraglutide
Pursuing the world's first-ever orally-dosed liraglutide
Polaris Renewable Energy Announces Q4 And Annual 2024 Results
TORONTO, ON / ACCESS Newswire / February 20, 2025 / Polaris Renewable Energy Inc. (TSX:PIF) ("Polaris Renewable Energy" or the "Company"), is pleased to report its financial and operating results for the year ended December 31, 2024. This earnings release should be read in conjunction with the Company's consolidated financial statements and management's discussion and analysis, which are available on the Company's website at www.PolarisREI.com and have been posted on SEDAR+ at www.sedarplus.ca. The dollar figures below are denominated in US Dollars unless noted otherwise.
Genflow Biosciences PLC Announces Advancements in SIRT6 Variant Patent Application
LONDON, UK / ACCESS Newswire / February 20, 2025 / Genflow Biosciences Plc (LSE:GENF)(OTCQB:GENFF) ("Genflow" or "the Company") an emerging leader in the field of longevity research, focused on developing therapeutic solutions for the prevention of age-related diseases is pleased to announce today that its exclusive, out-licensed patent application for "Variants of SIRT6 for Use in Preventing and/or Treating Age-Related Diseases" has successfully progressed through the Supplementary European Search Report without further questions from the European Patent Office (EPO).
Could 'terrorist' designation lead to US strikes on drug cartels?
US President Donald Trump's decision to designate eight Latin American drug trafficking groups as "terrorist" organizations has raised speculation about possible military action on foreign soil.
No immediate ruling on 'unusual' move to drop New York mayor corruption case
A US federal judge peppered a top member of Donald Trump's Justice Department with questions Wednesday during a hearing over the office's extraordinary move to drop corruption charges against New York Mayor Eric Adams.
Yoon to become South Korea's first sitting president to go on criminal trial
Ousted South Korean leader Yoon Suk Yeol will become the country's first sitting head of state to stand trial in a criminal case as hearings open Thursday on his bid to impose martial law.
Latin America's 'terrorist' cartels in Trump's sights
From Mexico's most ruthless drug cartels to Central America's most notorious street gang, these are the eight drug trafficking groups being designated terrorist organizations by US President Donald Trump's administration:
Pope's tests show improvement, Italy PM visits
Pope Francis's blood tests show a "slight improvement" as he receives hospital treatment for pneumonia, the Vatican said Wednesday, while Italy's prime minister found the 88-year-old joking "as always".
Syrian Jews say held first group prayer in decades in Damascus synagogue
Syria's tiny Jewish community said they held their first group prayer in decades Wednesday, in a synagogue in Damascus's Old City, expressing joy at the long-awaited return to public worship.
Call for 'maximum' sentence for Bosnian Serb leader
Prosecutors demanded a near five-year jail sentence Wednesday for Bosnian Serb leader Milorad Dodik for defying the envoy who oversees the peace accords that ended the country's bloody 1990s war.
UK accusers of influencer Tate urge US to stay away from case
Four British women who have accused notorious influencer Andrew Tate of rape said Wednesday they were "concerned" by reports the US government was petitioning Romania to ease his travel restrictions.
Teamwork key to smashing European doping networks: WADA investigations chief
A collaboration between the Serbian anti-doping agency and law enforcement operatives who seized 3,000 kilogrammes of performance-enhancing drugs and broke up an organised crime gang last year is "the future in the fight against doping", WADA's Director of Intelligence and Investigations Gunter Younger has told AFP.
Pope 'breathing on his own' despite pneumonia: Vatican source
Pope Francis's heart is holding up very well despite his pneumonia, a Vatican source said Wednesday, amid growing concerns over the hospitalised 88-year-old's condition.
UK govt cracks down on online knife sales
A new law introduced after a spate of high-profile knife crimes will make it harder for young people to purchase knives online, the UK government announced Wednesday.
Pope, suffering from pneumonia, had 'peaceful night'
Pope Francis, who has been diagnosed with pneumonia in both lungs, passed a "peaceful night", the Vatican said Wednesday, amid growing concerns over the 88-year-old's condition.
Peru's 12-Angle Stone vandalized, causing 'irreversible damage'
An allegedly intoxicated man vandalized a 500-year-old archaeological artifact known as the 12-Angle Stone in Peru, authorities said Tuesday.
UN watchdog chief visits Fukushima as Japan returns to nuclear power
The UN nuclear watchdog chief visited Japan's stricken Fukushima plant on Wednesday, the day after Tokyo approved an energy plan that marks a return to nuclear power to meet growing demand for AI.
Top South Korean judge faces disinformation deluge as Yoon impeachment looms
Bogus child pornography claims, fabricated support for communism and fake posts showing Elon Musk calling for his removal -- a deluge of disinformation is targeting a top judge in suspended South Korean President Yoon Suk Yeol's impeachment trial.
Rapper A$AP Rocky found not guilty in assault trial
Rapper A$AP Rocky was found not guilty of two counts of felony assault at the conclusion of a trial in Los Angeles on Tuesday.
Havertys Announces First Quarter 2025 Cash Dividend
ATLANTA, GA / ACCESS Newswire / February 19, 2025 / HAVERTYS (NYSE:HVT and HVT.A) announced today that its board of directors declared a cash dividend to be paid on the outstanding shares of the two classes of $1 par value common stock of the company at a rate of $0.32 per share on the common stock and $0.30 per share on the Class A common stock. The dividend is payable on March 21, 2025, to stockholders of record at the close of business on March 6, 2025. Havertys has paid a cash dividend in each year since 1935.
Bausch Health Announces Fourth Quarter and Full-Year 2024 Results
Seventh consecutive quarter of year-over-year growth in both Revenue and Adjusted EBITDA (non-GAAP)1, delivering results at the high-end and/or exceeding 2024 guidanceFourth Quarter Consolidated Revenues of $2.56 billion, up 6% on a Reported basis and up 9% on an Organic (non-GAAP)1 basis over the prior year periodFull-Year Consolidated Revenues of $9.63 billion, up 10% on a Reported basis and 8% on an Organic (non-GAAP)1 basis, with growth in all segmentsGAAP Net Income Attributable to Bausch Health Companies Inc. of $93 million for the quarter and GAAP Net Loss of $46 million for the yearConsolidated Adjusted EBITDA Attributable to Bausch Health Companies Inc. (non-GAAP)1 of $935 million for the quarter, up 8%, and $3.31 billion for the year, up 10%
Hemogenyx Pharmaceuticals PLC Announces Issue of Convertible Loan Notes
LONDON, UK / ACCESS Newswire / February 19, 2025 / NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO OR FROM THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, THE REPUBLIC OF SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE IT IS UNLAWFUL TO DISTRIBUTE THIS ANNOUNCEMENT.
Aspire Biopharma Holdings, Inc., Announces Public Listing on Nasdaq
NEW YORK CITY, NY / ACCESS Newswire / February 19, 2025 / Aspire Biopharma, Inc. ("Aspire" or the "Company"), a developer of a multi-faceted patent-protected disruptive drug delivery mechanism technology, and PowerUp Acquisition Corp. (Nasdaq:PWUP), a Nasdaq Global Market® listed special purpose acquisition company, ("PowerUp"), today announced the completion of their previously announced business combination (the "Business Combination"). The Business Combination was approved by PowerUp Acquisition Corp. stockholders on January 31, 2025, and it closed on February 17, 2025. Beginning on February 20, 2025, Aspire Biopharma shares of common stock and warrants will begin to trade on the Nasdaq Global Market and Nasdaq Capital Market (collectively, "Nasdaq"), respectively, under the ticker symbols "ASBP" and "ASBPW," respectively.